Business Development

HaiHe Biopharma seeks for external partnerships continuously.

  • Out-licensing/co-development


    HaiHe Biopharma owns global rights for multiple inhouse developed projects, and would like to discuss potential mutually beneficial out-licensing or codevelopment opportunities with global partners.

  • Combination therapy

    2.Combination therapy:

    With the robust and balanced R&D pipeline, we would like to explore potential partnerships in combination with immune-oncological drugs,

    targeted drugs, and chemo-therapeutic drugs.

  • oint marketing

    3.Joint marketing:

    HaiHe Biopharma focuses on discovery, development and commercialization of innovative anti-tumor drugs.

    We plans to set up our own sales team, and actively seeks for partnerships in sales.

  • In-licensing


    Besides in-house development, HaiHe Biopharma is open to both small molecule and biologics in-licensing opportunities to expand and strengthen the R&D pipeline.


Address: No. 421 Newton Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai

@2019 Copyright Shanghai HaiHe Pharmaceutical Co.,Ltd All Rights Reserved.

All Rights Reserved. 沪ICP备12016151号

HaiHe Biopharma

on Wechat